Ultra-deep sequencing improves the detection of drug resistance in cellular DNA from HIV-infected patients on ART with suppressed viraemia
Author(s) -
Christophe Rodriguez,
Marie Laure Néré,
Vanessa Démontant,
Isabelle Charreau,
Mélanie Mercier-Darty,
Héloïse Delagrèverie,
Maud Salmona,
Nathalie De Castro,
MarieLaure Chaix,
JeanMichel Molina,
Constance Delaugerre
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky315
Subject(s) - genotype , biology , dna sequencing , reverse transcriptase , virology , drug resistance , dna , hiv drug resistance , resistance mutation , deep sequencing , gene , polymerase chain reaction , microbiology and biotechnology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , genetics , genome
Standard genotypic tests performed on HIV DNA from patients on suppressive ART, with previous resistance-associated mutations (RAMs) detected in their plasma, underestimate resistance. We thus compared ultra-deep sequencing (UDS) with bulk sequencing of DNA to detect RAMs previously identified in plasma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom